Not all patients with CLL need therapy. Inspite of all recent improvements, the iwCLL even now endorses watchful observation for patients with asymptomatic illness.86 This advice relies on at the least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both equally trials concluded https://situsjudimbl7766655.blogpayz.com/32529289/a-secret-weapon-for-link-alternatif-mbl77